|
BA76562 |
2-hydroxy-N-[(5Z)-5-[(3-hydroxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]benzamide |
299952-93-5 |
C17H12N2O4S2 |
372.4182 |
VIEW DETAILS > |
|
BH45293 |
N-[(5Z)-5-(3-ethoxy-4-hydroxybenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-2-hydroxybenzamide |
299952-94-6 |
C19H16N2O5S2 |
416.4707 |
VIEW DETAILS > |
|
AX82570 |
{3-[3-(2-Hydroxy-benzoylamino)-4-oxo-2-thioxo-thiazolidin-5-ylidene]-2-oxo-2,3-dihydro-indol-1-yl}-acetic acid |
299952-96-8 |
C20H13N3O6S2 |
455.4637 |
VIEW DETAILS > |
|
BH45434 |
3-(5-(2-methoxybenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)-N-(4-sulfamoylphenyl)propanamide |
299952-97-9 |
C20H19N3O5S3 |
477.5770 |
VIEW DETAILS > |
|
BV23574 |
3-[(5Z)-5-[(2-methoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]propanamide |
299952-98-0 |
C23H20N4O5S4 |
560.6887 |
VIEW DETAILS > |
|
BH45428 |
3-Thiazolidinepropanamide, 5-[(4-methylphenyl)methylene]-4-oxo-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-2-thioxo-, (5Z)- |
299952-99-1 |
C23H20N4O4S4 |
544.6893 |
VIEW DETAILS > |
|
AD52159 |
MRN-ATM Pathway Inhibitor, Mirin |
299953-00-7 |
C10H8N2O2S |
220.2477 |
VIEW DETAILS > |
|
BH45811 |
(5Z)-5-(3,4-dimethoxybenzylidene)-3-(2,4-dimethylphenyl)-2-thioxo-1,3-thiazolidin-4-one |
299953-03-0 |
C20H19NO3S2 |
385.4998 |
VIEW DETAILS > |
|
BV16862 |
(5E)-3-(2,3-dimethylphenyl)-5-[(3-nitrophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one |
299953-05-2 |
C18H14N2O3S2 |
370.4454 |
VIEW DETAILS > |
|
AF36564 |
5-(4-methoxybenzyl)thiazol-2-amine |
299953-06-3 |
C11H12N2OS |
220.2908 |
VIEW DETAILS > |